Recombinant Vaccines Market Report

Global and Region Recombinant Vaccines Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：229
  • REPORT CODE：GMM963989
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Recombinant vaccines are one of the most important tools in the medical industry today. These vaccines help prevent the spread of many infectious diseases, such as hepatitis B. In recent years, the growth of the market has been driven by a sharp increase in the incidence of infectious diseases, increased regulatory approvals, increased awareness of health care, and continued innovation in drug and vaccine development.

    The report details the trend, potential and market size of Recombinant Vaccines market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Recombinant Vaccinesmarket, defines the market attractiveness level of Recombinant Vaccines market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Recombinant Vaccines industry, describes the types of Recombinant Vaccines market, the applications of major players and the market size, and deeply analyzes the current situation of the global Recombinant Vaccines market and the development prospects and opportunities of Recombinant Vaccines industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Recombinant Vaccines market in Chapter 13.

    By Player:

    • GlaxoSmithKline Plc

    • Green Cross Corporation

    • Bayer AG

    • Novartis AG

    • Sanofi S A

    • Pfizer Inc

    • Merck & Co, Inc

    • Bharat Biotech

    • Protein Science Corporation

    By Type:

    • Subunit Recombinant Vaccines

    • Attenuated Recombinant Vaccines

    • Vector Recombinant Vaccines

    By End-User:

    • Hospitals & clinics

    • Pediatrics

    • Adults

    • Veterinary

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Recombinant Vaccines Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Recombinant Vaccines Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Recombinant Vaccines Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Recombinant Vaccines Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Recombinant Vaccines Market Analysis and Outlook to 2022

    • 7.1 Global Recombinant Vaccines Consumption (2017-2022)

    • 7.2 United States Recombinant Vaccines Consumption (2017-2022)

    • 7.3 Europe Recombinant Vaccines Consumption (2017-2022)

    • 7.4 China Recombinant Vaccines Consumption (2017-2022)

    • 7.5 Japan Recombinant Vaccines Consumption (2017-2022)

    • 7.6 India Recombinant Vaccines Consumption (2017-2022)

    • 7.7 South Korea Recombinant Vaccines Consumption (2017-2022)

    8 Region and Country-wise Recombinant Vaccines Market Analysis and Outlook to 2028

    • 8.1 Global Recombinant Vaccines Consumption Forecast (2022-2028)

    • 8.2 United States Recombinant Vaccines Consumption Forecast (2022-2028)

    • 8.3 Europe Recombinant Vaccines Consumption Forecast (2022-2028)

    • 8.4 China Recombinant Vaccines Consumption Forecast (2022-2028)

    • 8.5 Japan Recombinant Vaccines Consumption Forecast (2022-2028)

    • 8.6 India Recombinant Vaccines Consumption Forecast (2022-2028)

    • 8.7 South Korea Recombinant Vaccines Consumption Forecast (2022-2028)

    9 Global Recombinant Vaccines Market Outlook by Types and Applications to 2022

    • 9.1 Global Recombinant Vaccines Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Subunit Recombinant Vaccines Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Attenuated Recombinant Vaccines Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Vector Recombinant Vaccines Consumption and Growth Rate (2017-2022)

    • 9.2 Global Recombinant Vaccines Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals & clinics Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Pediatrics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Adults Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Veterinary Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Recombinant Vaccines Market Outlook by Types and Applications to 2028

    • 10.1 Global Recombinant Vaccines Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Subunit Recombinant Vaccines Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Attenuated Recombinant Vaccines Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Vector Recombinant Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Recombinant Vaccines Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals & clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Pediatrics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Adults Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Veterinary Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Recombinant Vaccines Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Recombinant Vaccines Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Recombinant Vaccines Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Recombinant Vaccines Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Recombinant Vaccines Market Competitive Analysis

    • 14.1 GlaxoSmithKline Plc

      • 14.1.1 GlaxoSmithKline Plc Company Details

      • 14.1.2 GlaxoSmithKline Plc Recombinant Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 GlaxoSmithKline Plc Recombinant Vaccines Product and Service

    • 14.2 Green Cross Corporation

      • 14.2.1 Green Cross Corporation Company Details

      • 14.2.2 Green Cross Corporation Recombinant Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Green Cross Corporation Recombinant Vaccines Product and Service

    • 14.3 Bayer AG

      • 14.3.1 Bayer AG Company Details

      • 14.3.2 Bayer AG Recombinant Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Bayer AG Recombinant Vaccines Product and Service

    • 14.4 Novartis AG

      • 14.4.1 Novartis AG Company Details

      • 14.4.2 Novartis AG Recombinant Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Novartis AG Recombinant Vaccines Product and Service

    • 14.5 Sanofi S A

      • 14.5.1 Sanofi S A Company Details

      • 14.5.2 Sanofi S A Recombinant Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Sanofi S A Recombinant Vaccines Product and Service

    • 14.6 Pfizer Inc

      • 14.6.1 Pfizer Inc Company Details

      • 14.6.2 Pfizer Inc Recombinant Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Pfizer Inc Recombinant Vaccines Product and Service

    • 14.7 Merck & Co, Inc

      • 14.7.1 Merck & Co, Inc Company Details

      • 14.7.2 Merck & Co, Inc Recombinant Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Merck & Co, Inc Recombinant Vaccines Product and Service

    • 14.8 Bharat Biotech

      • 14.8.1 Bharat Biotech Company Details

      • 14.8.2 Bharat Biotech Recombinant Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Bharat Biotech Recombinant Vaccines Product and Service

    • 14.9 Protein Science Corporation

      • 14.9.1 Protein Science Corporation Company Details

      • 14.9.2 Protein Science Corporation Recombinant Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Protein Science Corporation Recombinant Vaccines Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Recombinant Vaccines

    • Figure Recombinant Vaccines Picture

    • Table Global Recombinant Vaccines Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Recombinant Vaccines Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Recombinant Vaccines Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Recombinant Vaccines Consumption by Country (2017-2022)

    • Figure United States Recombinant Vaccines Consumption and Growth Rate (2017-2022)

    • Table Europe Recombinant Vaccines Consumption and Growth Rate (2017-2022)

    • Figure China Recombinant Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Japan Recombinant Vaccines Consumption and Growth Rate (2017-2022)

    • Figure India Recombinant Vaccines Consumption and Growth Rate (2017-2022)

    • Figure South Korea Recombinant Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Recombinant Vaccines Consumption Forecast by Country (2022-2028)

    • Figure United States Recombinant Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Recombinant Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Recombinant Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Recombinant Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Recombinant Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Recombinant Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Subunit Recombinant Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Attenuated Recombinant Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Vector Recombinant Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals & clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Pediatrics Consumption and Growth Rate (2017-2022)

    • Figure Global Adults Consumption and Growth Rate (2017-2022)

    • Figure Global Veterinary Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Subunit Recombinant Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Attenuated Recombinant Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Vector Recombinant Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals & clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pediatrics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Adults Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Veterinary Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Recombinant Vaccines Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Recombinant Vaccines Export by Region (Top 5 Countries) (2017-2028)

    • Table GlaxoSmithKline Plc (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Plc Recombinant Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Plc Recombinant Vaccines Product and Service

    • Table Green Cross Corporation (Foundation Year, Company Profile and etc.)

    • Table Green Cross Corporation Recombinant Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Green Cross Corporation Recombinant Vaccines Product and Service

    • Table Bayer AG (Foundation Year, Company Profile and etc.)

    • Table Bayer AG Recombinant Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer AG Recombinant Vaccines Product and Service

    • Table Novartis AG (Foundation Year, Company Profile and etc.)

    • Table Novartis AG Recombinant Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG Recombinant Vaccines Product and Service

    • Table Sanofi S A (Foundation Year, Company Profile and etc.)

    • Table Sanofi S A Recombinant Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi S A Recombinant Vaccines Product and Service

    • Table Pfizer Inc (Foundation Year, Company Profile and etc.)

    • Table Pfizer Inc Recombinant Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Inc Recombinant Vaccines Product and Service

    • Table Merck & Co, Inc (Foundation Year, Company Profile and etc.)

    • Table Merck & Co, Inc Recombinant Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck & Co, Inc Recombinant Vaccines Product and Service

    • Table Bharat Biotech (Foundation Year, Company Profile and etc.)

    • Table Bharat Biotech Recombinant Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bharat Biotech Recombinant Vaccines Product and Service

    • Table Protein Science Corporation (Foundation Year, Company Profile and etc.)

    • Table Protein Science Corporation Recombinant Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Protein Science Corporation Recombinant Vaccines Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US